Meridian Life Science, Inc. is a premier partner for contract R&D,
process development, and clinical cGMP biomanufacturing for:
• Vaccines
• Viral challenge materials
• Virus-like particles
• Vectored gene therapies
• Recombinant proteins
|
|
Services include:
• Cell and viral banking
• Process development
• Scale-up
• Downstream processing
• Formulations/stability
• Fill and finish to support cGMP biologics production
|
| cGMP Biopharmaceutical Manufacturing: |
|
Why Partner with Meridian Life Science? |
|
| |
|
|
|
- Focus Areas:
- Recombinant, live and attenuated
- Virus-like particles
- Oncolytic and therapeutic vaccines
- Viral challenge materials
- Gene therapies (viral vectored)
- Adenovirus, AAV, HSV, Vaccinia, Lentivirus, etc.
- Recombinant proteins in BEVS
|
 |
- Proven track record of clinical production
- Over 25 years experience in:
- cell culture
- virus production
- protein purification
- assay development
- regulatory compliance
- Dedicated team of:
- Ph.D. Virologists
- Cell Biologists
- Protein Chemists
- Trusted sole source supplier of critical raw materials
- Mature quality system
- Customization of processes to accommodate your needs
- Integration of special requirements and/or instrumentation
- Flexible scheduling
- All requests for services and products are considered confidential
|
 |
- Expression System:
- Mammalian cell culture
- Insect cell/Baculovirus system
- Egg-based virus production
- Plasmid transfection
- cGMP Production:
- Master and working cell and viral banks
- Multiple cGMP clean rooms for Phase I/II clinical products
- Uninfected and infected eukaryotic cell culture suites
- Clinical fill and finish capacity
|
 |